Stereotaxis (STXS) said Thursday it signed deals to sell about $12.5 million worth of common stock through a registered direct offering priced at $2 apiece.
The company said the first closing, totaling $8.5 million, is expected around Friday, with the remaining $4 million scheduled to close by Nov. 25.
Proceeds will likely support product launches, research efforts, and general operations, Stereotaxis said.
The company's shares were down nearly 9% in recent Thursday premarket activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.